What changed
$OGN — WATCHLIST 📊
Organon & Co.
🎯 Q2 2026 | Rev $1B | EPS $0.71 vs $0.85 🔴
💡 The market expected earnings to hold near consensus, but the 17% miss suggests either temporary headwinds (one-time costs, unfavorable mix) or a more sustained erosion in legacy products. My variant view is that the sell-off may overstate the damage, but lack of forward guidance leaves that untestable in the short run.
📉 Reward/risk: 2.06:1
🏢 Business Quality: 6/10
📊 Valuation: cheap — trailing P/E near 4.8x (annualizing $0.71), but forward estimates likely fall. EV/EBITDA below 6x.
🔮 Catalyst: recent earnings miss
💰 Entry: $13.48, stop $12.5, target $15.5
⚖️ Watchlist: recent earnings miss removes the near-term thesis, and with no catalyst in the next 3 months, the risk-reward is not clearly favorable.
📊 Our read: WATCHLIST. Full analysis →
https://stockduty.xyz/s/OGN0625